Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01723696 · ClinicalTrials.gov registry record · Phase 2
Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function
A Phase 2 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 2
- Development phase
- 252
- Enrollment target
NCT01723696 is a Phase 2 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 252 participants.
The verdict
NCT01723696, a Phase 2 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 252 participants
- Enrollment target
Study Summary
Vitamin C supplementation (500 mg per day) given to pregnant women who can not quit smoking will improve the pulmonary function tests in their offspring measured at 3 months of age.
Interventions
- DIETARY_SUPPLEMENT Vitamin C +prenatal vitamin
- DIETARY_SUPPLEMENT Placebo tablet+prenatal vitamin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2012-12 |
| Est. Completion | 2017-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01723696
The ClinicalTrials.gov registry entry for NCT01723696 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin C +prenatal vitamin is the first listed.
NCT01723696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01723696 about?
NCT01723696 is a clinical study titled "Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function". Vitamin C supplementation (500 mg per day) given to pregnant women who can not quit smoking will improve the pulmonary function tests in their offspring measured at 3 months of age.
What is the current status of trial NCT01723696?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 252 participants. The study started on 2012-12. Estimated completion is 2017-12.
What interventions are being tested in trial NCT01723696?
The interventions under investigation include: Vitamin C +prenatal vitamin (DIETARY_SUPPLEMENT), Placebo tablet+prenatal vitamin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01723696?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.